Nanomedicines for Breast Cancer Theranostics
Elsevier Science Publishing Co Inc (Verlag)
978-0-12-820016-2 (ISBN)
Dr. Nanasaheb Thorat is Principal Investigator funded by the Science Foundation Ireland (SFI) and Irish Research Council (IRC) Pathway Program at the University of Limerick, Ireland. He is also a Marie Curie Visiting Research Scientist at the University of Oxford, UK. He has been deeply engaged in collaborative work with the many eminent scientists from Japan, USA, Germany, Korea, Ireland, India, Poland, Saudi Arabia and Australia. Dr. Thorat has received the European Commission’s innovation Radar “Grand Prix of the Innovation Radar Prize 2020 for developing ground-breaking technology for breast cancer theranostics. Joanna Bauer is Assistant Professor at the Department of Biomedical Engineering at the Wroclaw University of Science and Technology, Poland. Her research focuses on multidisciplinary biomedical engineering projects related to personalized and preventive medicine, nano-biomaterials synthesis, characterization and functionalization, biomedical optics using visible and infrared.imaging, as well as image analysis and pattern recognition.
1. Nanomedicine: next generation modality of breast cancer therapeutics 2. Physical and Chemical properties of nanostructures 3. Biological Perspectives of Hybrid nanostructures 4. Novel hybrid nanostructures in breast cancer nanomedicine 5. Synergy between nanoparticles and breast cancer theranostics 6. Remotely stimulated Nano medicine for breast cancer therapy 7. Functional Nanostructures for drug resistant breast cancer theranostics 8. Nanomedicine for early diagnosis of breast cancer 9. Nanomedicine strategies for chemoresistant breast cancer theranostics 10. Cellular Interaction and Toxicity of Nanostructures 11. Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship 12. A New Approach for Cancer Treatment: from Specific Induction of Breast Cancer to Innovative Gold-Nanoparticle Mediated Thermal Therapies 13. Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine 14. Consensus protocols for animal experimentation and nanomedicine trials at clinical stage in breast cancer 15. Current development in toxicity, clinical trials guidelines for regulatory aspects of breast cancer nanomedicines 16. Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine
Erscheinungsdatum | 14.03.2020 |
---|---|
Reihe/Serie | Micro & Nano Technologies |
Sprache | englisch |
Maße | 191 x 235 mm |
Gewicht | 880 g |
Themenwelt | Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie |
Technik ► Maschinenbau | |
Technik ► Medizintechnik | |
ISBN-10 | 0-12-820016-2 / 0128200162 |
ISBN-13 | 978-0-12-820016-2 / 9780128200162 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich